Orion Portfolio Solutions LLC Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Orion Portfolio Solutions LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 86,906 shares of the healthcare conglomerate’s stock after selling 2,861 shares during the period. Orion Portfolio Solutions LLC’s holdings in UnitedHealth Group were worth $43,962,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. Finally, Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 0.4 %

Shares of NYSE UNH opened at $515.89 on Friday. The firm has a market cap of $471.89 billion, a PE ratio of 33.28, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business has a fifty day simple moving average of $508.70 and a two-hundred day simple moving average of $545.16.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.83 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.63%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Stephens boosted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.